Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abatacept”

214 trials

Showing 20 of 214 results

Large-scale testing (Phase 3)Study completedNCT01844895
What this trial is testing

Methotrexate-Inadequate Response Autoinjector Device Sub Study

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Study completedNCT00420199
What this trial is testing

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Active Rheumatoid Arthritis
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT00442611
What this trial is testing

Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Who this might be right for
Scleroderma, DiffuseScleroderma, Systemic
Stanford University 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04909801
What this trial is testing

Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 338
Testing effectiveness (Phase 2)Study completedNCT03680092
What this trial is testing

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Who this might be right for
GVHDHematologic Neoplasms
Dimitrios Tzachanis, MD PhD 43
Early research (Phase 1)Study completedNCT06929039
What this trial is testing

Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA
Kashiv BioSciences, LLC 300
Not applicableStudy completedNCT02547493
What this trial is testing

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
University Hospital, Montpellier 80
Post-approval studies (Phase 4)Study completedNCT03652961
What this trial is testing

Rheumatoid Arthritis Memory B Cells and Abatacept

Who this might be right for
Rheumatoid Arthritis
NYU Langone Health 25
Early research (Phase 1)Study completedNCT02923583
What this trial is testing

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Who this might be right for
Healthy Volunteers
Momenta Pharmaceuticals, Inc. 243
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Very early researchEnded earlyNCT03059888
What this trial is testing

Trial of Orencia in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Johns Hopkins University 6
Not applicableStudy completedNCT01555879
What this trial is testing

Real-world Clinical Efficacy of Abatacept in the T3 Data Registry

Who this might be right for
Arthritis, Rheumatoid
Arthritis Northwest PLLC 200
Not applicableStudy completedNCT01094795
What this trial is testing

Safety Study of Abatacept in Sweden

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 92,635
Large-scale testing (Phase 3)Study completedNCT00095173
What this trial is testing

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Bristol-Myers Squibb 214
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Testing effectiveness (Phase 2)WithdrawnNCT02027298
What this trial is testing

Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study

Who this might be right for
Primary Sjogren's SyndromeSecondary Sjogren's SyndromeInflammatory Arthritis+1 more
The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT00886795
What this trial is testing

Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy

Who this might be right for
Urticaria
Johns Hopkins University 4
Testing effectiveness (Phase 2)Study completedNCT02270957
What this trial is testing

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 66
Early research (Phase 1)Study completedNCT01272856
What this trial is testing

Study on the Safety of Abatacept in Relapsing Polychondritis

Who this might be right for
Relapsing Polychondritis
Benaroya Research Institute 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04955366
What this trial is testing

Abatacept Conversion in Kidney Transplantation

Who this might be right for
Renal Transplant Recipient
Emory University 87
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation